The Robustness of Pathway Analysis in Identifying Potential Drug Targets in Non-Small Cell Lung Carcinoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27600345)

Published in Microarrays (Basel) on October 27, 2014

Authors

Andrew Dalby1, Ian Bailey2

Author Affiliations

1: Faculty of Science and Technology, University of Westminster, Westminster W1W 6UW, UK. A.Dalby@westminster.ac.uk.
2: Faculty of Science and Technology, University of Westminster, Westminster W1W 6UW, UK. I.Bailey@westminster.ac.uk.

Articles cited by this

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34

Wnt signalling in stem cells and cancer. Nature (2005) 19.26

Comprehensive genomic characterization of squamous cell lung cancers. Nature (2012) 18.90

Wnt signaling and cancer. Genes Dev (2000) 18.53

Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet (2006) 16.12

The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell (2002) 13.92

ArrayExpress update--from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res (2008) 12.45

Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res (2010) 11.23

RHO-GTPases and cancer. Nat Rev Cancer (2002) 8.03

Fundamentals of experimental design for cDNA microarrays. Nat Genet (2002) 7.49

The new World Health Organization classification of lung tumours. Eur Respir J (2001) 6.91

Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer (2006) 4.99

Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol (2000) 3.49

On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci U S A (2005) 3.48

HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene (2011) 2.42

A genomics-based classification of human lung tumors. Sci Transl Med (2013) 2.41

Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res (2004) 2.07

Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin Cancer Res (2012) 1.95

TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev Biol (2002) 1.93

Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun (2000) 1.52

Platelets: linking hemostasis and cancer. Arterioscler Thromb Vasc Biol (2010) 1.29

L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett (2009) 1.25

Loss of ataxia telangiectasia mutated- and Rad3-related function potentiates the effects of chemotherapeutic drugs on cancer cell survival. Mol Cancer Ther (2007) 1.24

Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers. J Transl Med (2008) 1.15

Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. J Thorac Oncol (2014) 1.13

Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol (2010) 1.13

ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer. Clin Cancer Res (2013) 1.11

Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis. J Clin Pathol (1986) 1.03

Activation of a novel ataxia-telangiectasia mutated and Rad3 related/checkpoint kinase 1-dependent prometaphase checkpoint in cancer cells by diallyl trisulfide, a promising cancer chemopreventive constituent of processed garlic. Mol Cancer Ther (2007) 0.98

Genetic pathways linking hemostasis and cancer. Thromb Res (2012) 0.93

The expression of glyceraldehyde-3-phosphate dehydrogenase associated cell cycle (GACC) genes correlates with cancer stage and poor survival in patients with solid tumors. PLoS One (2013) 0.88

Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary study. Carcinogenesis (2008) 0.86

Expression of G protein-coupled receptor 19 in human lung cancer cells is triggered by entry into S-phase and supports G(2)-M cell-cycle progression. Mol Cancer Res (2012) 0.84

Analysis of gene expression data from non-small cell lung carcinoma cell lines reveals distinct sub-classes from those identified at the phenotype level. PLoS One (2012) 0.78

[Hemostasis and cancer]. Rev Clin Esp (1989) 0.77